Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Transplantation Proceedings

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0041-1345(00)01417-2PMID 11119890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conversion from sandimmune to neoral in renal allograft recipients

  1999cited by this paper
• Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

  1998cited by this paper
• Renal function following conversion from Sandimmune to Neoral in stable renal transplant recipients.

  1997cited by this paper
• Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.

  1996cited by this paper
• Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups.

  1996cited by this paper
• Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups.

  1996cited by this paper
• Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.

  1995cited by this paper
• CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION—A MULTICENTER INVESTIGATION IN KIDNEY TRANSPLANT PATIENTS

  1994cited by this paper
• THE ADVERSE IMPACT OF HIGH CYCLOSPORINE: CLEARANCE RATES ON THE INCIDENCES OF ACUTE REJECTION AND GRAFT LOSS

  1993cited by this paper

• Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patients.

  2002cites this paper